甲状腺癌的微血管密度及其临床意义

被引:13
作者
薛刚
姚榛祥
机构
[1] 重庆医科大学附属第一医院普外科,重庆医科大学附属第一医院普外科
关键词
甲状腺癌; 单克隆抗体; 微血管密度; 甲状腺癌组织; 临床意义;
D O I
暂无
中图分类号
R736.1 [甲状腺肿瘤];
学科分类号
100214 ;
摘要
引用
收藏
页码:75+83 / 75+83
页数:2
相关论文
共 6 条
[1]  
En dostatin :anendogenousinhibitorofangiogene sisandtumorgrowth. O′ReillyMS,BochmT,ShingY ,etal. Cell . 1 997
[2]  
J: Tumor angiogenesis: Therapeutic implication. Folkman. The New England Journal of Medicine . 1971
[3]  
Tumor angiogenesis as a prognostic marker in operable non-small cell lung cancer. Matsuyama K.Chiba Y,Sasaki M,et al. The Annals of Thoracic Surgery . 1998
[4]  
Prospectivestudyofintratumoralmicroves seldensity ,p53expressionandsurvivalincol orectalcancer. VermeulenPB,VandenEGG,HuggerP,etal. British Journal of Cancer . 1999
[5]  
P53, vessel count, and vascular endothelial growth factor expression in human colon cancer. Takahashi Y,Bucana C D,Cleary K R,et al. International Journal of Cancer . 1998
[6]  
Current pathologic methods for measuring intratumoral microvessel density within breast carcinoma and other solid tumors. Weidner N. Breast Cancer Research . 1995